Asset Management One’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.8M Buy
65,660
+1,494
+2% +$310K 0.03% 411
2026
Q1
$14.4M Sell
64,166
-946
-1% -$236K 0.04% 358
2025
Q4
$15.8M Sell
65,112
-1,562
-2% -$399K 0.04% 347
2025
Q3
$18.3M Buy
66,674
+4,349
+7% +$1.19M 0.05% 311
2025
Q2
$16.1M Sell
62,325
-1,861
-3% -$444K 0.05% 325
2025
Q1
$14.4M Buy
64,186
+3,697
+6% +$863K 0.05% 351
2024
Q4
$14.1M Buy
60,489
+1,629
+3% +$392K 0.05% 346
2024
Q3
$14.4M Buy
58,860
+2,878
+5% +$643K 0.05% 342
2024
Q2
$10.7M Sell
55,982
-879
-2% -$178K 0.04% 389
2024
Q1
$11.3M Sell
56,861
-4,008
-7% -$734K 0.04% 391
2023
Q4
$10.5M Buy
60,869
+1,434
+2% +$220K 0.04% 402
2023
Q3
$8.79M Sell
59,435
-1,905
-3% -$344K 0.04% 424
2023
Q2
$13.4M Buy
61,340
+364
+0.6% +$81.1K 0.06% 345
2023
Q1
$13.4M Buy
60,976
+2,288
+4% +$496K 0.06% 335
2022
Q4
$12.3M Sell
58,688
-2,080
-3% -$457K 0.06% 345
2022
Q3
$13.3M Sell
60,768
-544
-0.9% -$124K 0.07% 305
2022
Q2
$12.9M Sell
61,312
-638
-1% -$136K 0.06% 326
2022
Q1
$15M Sell
61,950
-8,694
-12% -$2.1M 0.06% 336
2021
Q4
$18.4M Sell
70,644
-2,297
-3% -$596K 0.06% 314
2021
Q3
$19.2M Buy
72,941
+4,136
+6% +$1.13M 0.07% 279
2021
Q2
$17M Sell
68,805
-2,323
-3% -$488K 0.06% 329
2021
Q1
$13.8M Sell
71,128
-12,872
-15% -$2.58M 0.05% 369
2020
Q4
$17.7M Buy
84,000
+11,782
+16% +$2.35M 0.07% 278
2020
Q3
$12.4M Sell
72,218
-4,350
-6% -$803K 0.06% 336
2020
Q2
$14.7M Sell
76,568
-3,707
-5% -$607K 0.07% 269
2020
Q1
$11.8M Buy
80,275
+3,575
+5% +$569K 0.07% 285
2019
Q4
$11.9M Buy
76,700
+19
+0% +$2.74K 0.05% 369
2019
Q3
$10.4M Sell
76,681
-167
-0.2% -$21.9K 0.05% 387
2019
Q2
$9.38M Buy
76,848
+3,157
+4% +$350K 0.05% 416
2019
Q1
$7.66M Sell
73,691
-193,751
-72% -$20M 0.04% 447
2018
Q4
$30.3M Buy
267,442
+5,181
+2% +$555K 0.07% 292
2018
Q3
$30.2M Buy
262,261
+2,808
+1% +$308K 0.06% 336
2018
Q2
$26.9M Buy
259,453
+237
+0.1% +$24K 0.06% 356
2018
Q1
$25.5M Sell
259,216
-10,499
-4% -$992K 0.06% 363
2017
Q4
$22.9M Buy
269,715
+15,154
+6% +$1.25M 0.05% 394
2017
Q3
$19.6M Buy
254,561
+8,695
+4% +$665K 0.05% 426
2017
Q2
$19.1M Buy
245,866
+22,493
+10% +$1.61M 0.05% 403
2017
Q1
$16.1M Sell
223,373
-15,276
-6% -$1.06M 0.04% 450
2016
Q4
$14.8M Buy
238,649
+225,308
+1,689% +$13.8M 0.04% 484
2016
Q3
$857K Hold
13,341
0.01% 907
2016
Q2
$829K Hold
13,341
0.01% 908
2016
Q1
$761K Hold
13,341
0.01% 952
2015
Q4
$725K Hold
13,341
0.01% 974
2015
Q3
$675K Hold
13,341
0.01% 979
2015
Q2
$741K Hold
13,341
0.01% 985
2015
Q1
$956K Hold
13,341
0.01% 899
2014
Q4
$757K Sell
13,341
-4,136
-24% -$216K 0.01% 934
2014
Q3
$872K Hold
17,477
0.01% 870
2014
Q2
$912K Sell
17,477
-10,055
-37% -$498K 0.01% 801
2014
Q1
$1.22M Buy
27,532
+8,700
+46% +$391K 0.02% 656
2013
Q4
$885K Sell
18,832
-65
-0.3% -$3.29K 0.01% 777
2013
Q3
$996K Sell
18,897
-11,525
-38% -$559K 0.02% 747
2013
Q2
$1.41M Buy
+30,422
New +$1.44M 0.02% 584

Other funds holding RMD

Asset Management One's RMD Position: Q2 2026 in Review

Asset Management One increased its ResMed (RMD) stake by 2.3% in Q2 2026, buying an estimated $310K and bringing the position to 65,660 shares worth $12.8M. The position accounts for 0.03% of the portfolio, ranked #411.

Asset Management One first reported a position in RMD in Q2 2013 and has held it in 53 quarters since. The position peaked at $30.3M in Q4 2018. 880 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Asset Management One held 65,660 shares of ResMed worth $12.8M as of Q2 2026.
  • Asset Management One bought 1,494 ResMed shares in Q2 2026, an estimated $310K.
  • ResMed made up 0.03% of Asset Management One's portfolio in Q2 2026, its #411 holding.
  • Asset Management One first reported a position in ResMed in Q2 2013 and has held it in 53 quarters since.
  • Asset Management One's ResMed position peaked at $30.3M in Q4 2018.
  • 880 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Asset Management One's 13F filing for Q2 2026, filed 28 Jul 2026.